Skip to content

PRQR - ProQR Therapeutics N.V. - AlphaYou

Discover Compare Pricing

Sign in Sign up

Home Smart money Buy calls Analyze

Back to stock searchP

ProQR Therapeutics BV

PRQR · NASDAQ

Save to watchlist

Price is syncing

Reported smart-money activity for this stock is still below.

P

PRQRProQR Therapeutics BV

Overview

No source-backed view yet. This page is available for price, fundamentals, and future receipts as coverage warms.

Key stats

Aug 20

52-wk high: $3.10
52-wk low: $1.33
Prev close: $2.20
Mkt cap: $313.3M
Beta: 0.03
P/S: 17.0x

Smart money

8 funds hold a position and insiders have been net buying.

Real smart money

Funds holding this stock

8 holders

Combined position$6.0M

CI
Citadel
Ken Griffin · Q2 2026 13F
$2.2M
position
TS
Two Sigma
Q2 2026 13F

Earnings

Reported Aug 6, 2026

Earnings came in 28.6% above what analysts expected.

Documents

Quarterly report10-Q Annual report10-K

Financials

Fundamentals

Is the business strong?

This company is not yet profitable.

Net margin: -228.2%
Market cap: $313M

Valuation

P/S17.01
P/B3.29

Quality

Operating margin-100.7%
ROE

Technicals

Technicals

Price structure

No data yet

Technicals sync when verified market data is available. No sample data is shown.

Company

Symbol: PRQR
Exchange: NASDAQ
Sector: HEALTHCARE
Industry: BIOTECHNOLOGY
Market cap: $313.28M
Beta: 0.03

Analysts

What do analysts expect?

Analyst target and ratings are on paid plans

See the 12-month consensus target and the buy/hold/sell rating split.

Unlock the full results

Research hubs
About
Editorial policy
Methodology
Source coverage
Corrections

Privacy
Terms
Refunds
Disclaimer

© 2026 AlphaYou. All rights reserved.Not financial advice. Do your own research. Informational data only; past performance does not predict future results.

P/B

3.3x

Profit margin

-228.2%

Op margin

-100.7%

ROE

-57.4%

$2.1M

position

WC

Walleye Capital

Q1 2026 13F

$984K

position

5 more holders

Lite opens all of them for $16.50/month, paid yearly.

Unlock all 5 holders

Coverage gaps for PRQR

No recent Congress trade
No recent market-voice mention

Earnings per share

-$0.10+28.6%

-$0.14 expected

Next report

What the street expects next

EPS expected

-$0.12

-$0.12 to -$0.12

Revenue expected

$5.0M

5 analysts

Last 30 days

1up0down

Analysts raising estimates

Estimate drift

+0.02

Change in 30 days

-57.4%

ROA-19.8%

Growth

Beta0.03